how to maintain muscle on semaglutide and Exercise ๐ Taking GLP-1 Medications? Don't
Description
10.1210/en.2011-1795 [DOI] [PubMed] [Google Scholar] Daniels, D
Abbreviations DM2: diabetes mellitus type 2 GCR: glucagon receptor GIPR: glucose-dependent insulinotropic peptide receptor GLP-1a: glucagon-like peptide-1 analogues HbA1c: glycated hemoglobin HCC: hepatocellular carcinoma MRI-PDFF: Magnetic Resonance Imaging-Proton Density Fat Fraction NAFLD: Non-alcoholic fatty liver disease NASH: non-alcoholic steatohepatitis NCT: National Clinical Trial number PPAR: Peroxisome Proliferator-Activated Receptor RCT: randomized clinical trial SGLT-2i: sodium-glucose co-transporter-2 inhibitors Declarations Funding None to declare

For the most current and accurate information, we recommend consulting the manufacturer's official website
Both drugs can cause weight loss through different mechanismstopiramate affects neuronal signalling, whilst semaglutide regulates appetite via hormonal pathways

Jpn Diabetes Soc
